Zeeshan Ahmed Khattak’s Post

CSF can deliver liquid biopsy results similar to blood. CSF is ideally suited for use in glioblastoma patients, CNS lymphomas and brain metastases. Learn more: https://lnkd.in/duiFUP8F #CSF #RNA #Glioblastoma 

Bilateral Adrenal lesions. Differentials- Histoplasmosis, TB, lymphoma, mets. USG guided transhepatic right adrenal lesion biopsy. #Bostonscientific #BARD MISSION 18G 20cm biospy needle. USG - #Siemenssequoia.

BiTEs or CAR-T for R/R Follicular Lymphoma? Key Insights from EHA2024 Attended a thought-provoking educational session at #EHA2024 in a unique format. After seeing numerous presentations, I think it's best to highlight the key points into a single slide. #ipsos #hematology #follicularlymphoma #immunotherapy #CARTtherapy #bispecificantibodies

🚀 Groundbreaking insights from EHA 2024! Prof Alexey Danilov from City of Hope National Medical Center presented a study comparing the efficacy and safety of bispecific antibodies EPCOR, MOSUN, and ODRO in patients with relapsed/refractory follicular lymphoma (R/R FL). This matching-adjusted indirect comparison sheds light on the potential benefits of these treatments for patients after at least two systemic therapies. Discover these updates.👇 For all EHA 2024 videos, find the link in the comments! #MediMix #EHA2024 #Hematology #FollicularLymphoma #CancerResearch #Innovation

Glioblastoma is a fast-growing type of brain tumor that is the most aggressive type of tumor of the central nervous system. Read our article to learn about advances in immunotherapy treatments and recent developments and news related to #Glioblastoma. https://lnkd.in/gJuE-e8j #oncologyresearch #clinicaltrials #clinicalresearch #MERITCRO #YourClinicalEndpointExpert

Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group. https://lnkd.in/ehSP5FjB

The phase III RADICALS-HD trial results were simultaneously published in two papers in The Lancet. lower risk prostate cancers do not fare better by adding 6 months of hormone treatment to radiotherapy following radical prostatectomy, compared with radiotherapy alone. On the other hand, adding 2 years of hormone treatment instead of 6 months only to radiotherapy (RT) did lead to better 10-year metastasis-free survival in men with a higher risk of recurrence. 

Elaine Binkley, MD, and Farzad Jamshidi, MD, PhD, discuss the benefits and drawbacks of different treatments for primary vitreoretinal lymphoma in the September issue. Read more: https://ow.ly/Us7650TqeAW #Retinalphysician #PVRL #ocularoncology

HepatoPredict, a prognostic tool supporting the decision of liver transplantation in hepatocellular carcinoma ♥️.  👉 https://kntn.ly/204e16d5 Developed by Ophiomics, distributed by Biocartis. #LiverTransplantation #Biocartis #Ophiomics #HepatoCellularCarcinoma #HCC #LT #LiverCancer #HepatoPredict

According to the latest results presented at #ESMOGI24, liver transplantation alongside chemotherapy shows remarkable results in a highly selected patient population with unresectable colorectal liver metastases. The TRANSMET trial reveals that this approach could quadruple the 5-year overall survival rate compared to chemotherapy alone. Read the #ESMODailyReporter to learn more about these findings in #ColorectalCancer. 👇 https://ow.ly/kt4M50SqOtY